We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

600036:SSEChina Merchants Bank Co., Ltd. Class A Analysis

Data as of 2026-05-29 - not real-time

CN¥38.01

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

China Merchants Bank (600036.SS) is trading at CNY 38.01, comfortably above its 20‑day SMA of 37.61 but still below the 50‑day SMA of 38.76, indicating short‑term price weakness. The stock sits near the calculated support of 36.78 and faces resistance around 39.02, while the 30‑day volatility of roughly 14 % and a low beta of 0.21 suggest limited market‑wide swings. Technical momentum is mixed: the MACD line (-0.46) has crossed above its signal (-0.52), producing a modest bullish histogram, yet the overall trend is flagged as bearish and volume is decreasing. Fundamentally, the bank delivers a robust operating margin of 62 % and a profit margin of 50 %, with ROE at 12 % and a massive cash pile of CNY 1.8 trillion against CNY 0.69 trillion of debt, underscoring a solid balance sheet.
Valuation is exceptionally attractive – the trailing PE of 6.66 is far below the industry average of 16.5 and the DCF‑derived fair value of CNY 233.9 implies a massive upside. The dividend yield of 8.12 % (payout ratio ~53 %) is both generous and sustainable given the strong earnings and cash flow generation. These fundamentals, combined with a low beta and modest sector risk, point to a value‑oriented investment thesis with upside potential over medium to long horizons.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price trading just above 20‑day SMA
  • bearish trend direction with decreasing volume
  • proximity to support level 36.78

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • significant valuation discount vs industry PE
  • high and sustainable dividend yield
  • strong profitability and capital ratios

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • DCF fair value suggests >500% upside
  • robust cash position and low leverage
  • consistent earnings growth and dividend policy

Key Metrics & Analysis

Financial Health

Revenue Growth1.70%
Profit Margin50.45%
P/E Ratio6.7
ROE11.92%
ROA1.17%
P/B Ratio0.8
Op. Cash FlowCN¥482.3B
Industry P/E16.5

Technical Analysis

TrendBearish
RSI51.5
SupportCN¥36.78
ResistanceCN¥39.02
MA 20CN¥37.61
MA 50CN¥38.76
MA 200CN¥40.87
MACDBullish
VolumeDecreasing
Fear & Greed Index93.13

Valuation

Fair ValueCN¥233.92
GradeUndervalued
TypeValue
Dividend Yield8.12%

Risk Assessment

Beta0.21
Volatility13.97%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.